Skip to main content

Select your state

Start My EvaluationCall (888) 315-1715

Dual-action GLP-1 therapy

Physician-guided tirzepatide

Access FDA-approved tirzepatide medications for better appetite control under a physician's supervision.

  • Dual hormone action
  • FDA-approved options
  • Once-weekly dosing
  • Licensed physicians
Tirzepatide weight loss medication

Overview

What is tirzepatide?

Tirzepatide is a dual-action medication that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, two hormones involved in appetite regulation and metabolic health.

At Ideal Physician Weight Loss, licensed physicians evaluate whether tirzepatide is clinically appropriate for your weight management goals. Prescriptions may include FDA-approved branded medications such as Zepbound® or Mounjaro®, or compounded options when medically appropriate.

Like all GLP-1 therapies, tirzepatide works best as part of a comprehensive physician-guided program that includes nutrition support, lifestyle guidance, and ongoing medical monitoring.

Dual action

How tirzepatide's dual mechanism works

1

GLP-1 receptor activation

Reduces appetite signals in the brain and slows gastric emptying, helping you feel fuller, longer.

Benefits

Why patients choose tirzepatide

Dual hormone action

Activates both GLP-1 and GIP receptors for enhanced appetite control and metabolic support.

Significant weight reduction

Clinical trials showed among the highest average body weight loss of any FDA-approved obesity medication studied.

Powerful appetite control

Patients often report substantial reductions in hunger and food preoccupation.

Once-weekly convenience

A single weekly injection fits easily into your routine with pharmacy-delivered supplies.

Physician oversight

Licensed doctors evaluate eligibility, prescribe, and monitor your progress throughout treatment.

Home pharmacy delivery

Prescriptions fulfilled by licensed U.S. pharmacies with discreet shipping in 3 to 5 business days.

Eligibility

Who is eligible

You may qualify if:

  • Patients in states served by our licensed telehealth physicians (50 states)

May not be appropriate if:

  • Certain pancreatic, gallbladder, or kidney conditions, assessed by your physician

Outcomes

Expected weight loss

Weeks 1–4

Dose escalation phase. Mild GI side effects are common and usually improve. Contact your healthcare provider for guidance.

Timeline

Treatment timeline

  1. 1

    Day 1 | Health Questionnaire & Free Care Team Call

    Complete a brief questionnaire about your health history and weight goals. A care team member will connect with you to better understand your needs and guide you through the next steps.

  2. 2

    Same Day | Physician Consultation

    Meet with a licensed physician via secure telehealth to review your health profile and determine if tirzepatide is clinically appropriate for you.

  3. 3

    If Approved | Prescription Approval & Treatment Plan

    Your provider approves the prescription and selects Zepbound®, Mounjaro®, or compounded tirzepatide based on your individual needs.

  4. 4

    3 to 5 Days | Medication Delivery

    Your prescription is fulfilled through a licensed pharmacy and shipped with injection supplies and instructions.

  5. 5

    Ongoing | Treatment Optimization

    Receive regular check-ins, dose adjustments, and continued support throughout your weight management journey.

Formulations

Tirzepatide options

Zepbound®

Zepbound®

Tirzepatide injection

FDA-approved for weight management

Dual-action medication targeting GLP-1 and GIP receptors, approved for chronic weight management in adults with obesity or overweight.

Mounjaro®

Mounjaro®

Tirzepatide injection

FDA-approved for type 2 diabetes

Contains tirzepatide and may be prescribed for weight management when a licensed provider determines it is clinically appropriate.

Compounded tirzepatide

Compounded tirzepatide

Same active ingredient

Physician-prescribed alternative

Compounded tirzepatide may be available when clinically appropriate and prescribed by your licensed physician.

Safety

Safety information

Tirzepatide requires a prescription and must be used under ongoing physician supervision.

Your provider conducts a thorough medical evaluation before prescribing and monitors you throughout treatment.

Doses are increased gradually over weeks to improve tolerability and reduce gastrointestinal side effects.

Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in animal studies. Discuss your personal and family history with your physician.

Not for use during pregnancy. Tell your doctor about all medications, including insulin or sulfonylureas.

Individual results may vary. All medications carry potential risks. This page is for educational purposes and does not replace professional medical advice.

Side effects

Possible side effects

Common side effects

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Indigestion
  • Injection site reactions

Serious side effects

  • Pancreatitis
  • Gallbladder problems
  • Kidney injury or worsening kidney disease
  • Severe allergic reactions
  • Low blood sugar (especially with insulin or sulfonylureas)

When to seek care: Reach out to your care team for persistent nausea or vomiting. Seek emergency care for severe abdominal pain, difficulty breathing, or signs of a serious allergic reaction.

FAQ

Tirzepatide questions

Insurance coverage varies based on your plan and medical eligibility. A $75 medical evaluation fee applies for the initial assessment. Our team can help you understand your options, and tirzepatide programs start at $399/month, including consultation, medication, and ongoing support.

Explore tirzepatide treatment

Schedule a consultation with a licensed physician to find out if tirzepatide is right for your weight loss journey.